These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6298267)

  • 21. Potentiation of interferon's antiviral activity by the mutually synergistic interaction of MuIFN-alpha/beta and MuIFN-gamma.
    Schwarz LA; Fleischmann CM; Fleischmann WR
    J Biol Response Mod; 1984 Dec; 3(6):608-12. PubMed ID: 6096507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bioassay for interferon type I based on inhibition of Sendai virus growth.
    Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW
    J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].
    Zolin VV; Luk'ianov AN; Nesterov AE; Kolokol'tsov AA; Torchilin VP; Popov VF; Vardanian NV; Antonov NA
    Vestn Ross Akad Med Nauk; 1993; (2):29-31. PubMed ID: 7688615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes.
    Peng FW; Duan ZJ; Zheng LS; Xie ZP; Gao HC; Zhang H; Li WP; Hou YD
    Protein Expr Purif; 2007 Jun; 53(2):356-62. PubMed ID: 17287131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Purification of recombinant human alpha-N-interferon on an immunosorbent made of serum polyclonal antibodies].
    Iovlev VI; Solov'eva IE; Kondrat'eva GA
    Tr Inst Im Pastera; 1985; 62():142-5. PubMed ID: 3035756
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures.
    Weck PK; Apperson S; May L; Stebbing N
    J Gen Virol; 1981 Nov; 57(Pt 1):233-7. PubMed ID: 6172550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral effects of bacteria-derived human leukocyte interferons against encephalomyocarditis virus infection of squirrel monkeys. Brief report.
    Stebbing N; Weck PK; Fenno JT; Estell DA; Rinderknecht E
    Arch Virol; 1983; 76(4):365-72. PubMed ID: 6312932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of antiviral activity induced by interferons alpha, beta, and gamma.
    Vogel SN; Friedman RM; Hogan MM
    Curr Protoc Immunol; 2001 May; Chapter 6():Unit 6.9. PubMed ID: 18432822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological activities and receptor binding of two human recombinant interferons and their hybrids.
    Meister A; Uzé G; Mogensen KE; Gresser I; Tovey MG; Grütter M; Meyer F
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1633-43. PubMed ID: 3016158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta.
    Nansen A; Randrup Thomsen A
    J Immunol; 2001 Jan; 166(2):982-8. PubMed ID: 11145676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An interferon assay based on yield reduction of vesicular stomatitis virus antigen measured by enzyme immunoassay.
    Salonen R; Salmi A
    J Virol Methods; 1982 Nov; 5(3-4):143-9. PubMed ID: 6296175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.
    Yousefi S; Escobar MR; Gouldin CW
    Am J Clin Pathol; 1985 Jun; 83(6):735-40. PubMed ID: 2988328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
    Wallach D
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
    Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
    J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro.
    Schanen C; Chieux V; Lobert PE; Harvey J; Hober D
    Microbiol Immunol; 2006; 50(1):19-24. PubMed ID: 16428869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
    Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
    Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.
    Witter F; Barouki F; Griffin D; Nadler P; Woods A; Wood D; Lietman P
    Clin Pharmacol Ther; 1987 Nov; 42(5):567-75. PubMed ID: 2445516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.